Screening applications in drug discovery based on microfluidic technology
Screening applications in drug discovery based on microfluidic technology
复制标题
DOI:
10.1063/1.4940886
复制
发表时间:
2016-01-01
期刊:
影响因子:
3.2
通讯作者:
Ulgen, K. O.
中科院分区:
文献类型:
--
作者:
Eribol, P.;Uguz, A. K.;Ulgen, K. O.
Microfluidics has been the focus of interest for the last two decades for all the advantages such as low chemical consumption, reduced analysis time, high throughput, better control of mass and heat transfer, downsizing a bench-top laboratory to a chip, i.e., lab-on-a-chip, and many others it has offered. Microfluidic technology quickly found applications in the pharmaceutical industry, which demands working with leading edge scientific and technological breakthroughs, as drug screening and commercialization are very long and expensive processes and require many tests due to unpredictable results. This review paper is on drug candidate screening methods with microfluidic technology and focuses specifically on fabrication techniques and materials for the microchip, types of flow such as continuous or discrete and their advantages, determination of kinetic parameters and their comparison with conventional systems, assessment of toxicities and cytotoxicities, concentration generations for high throughput, and the computational methods that were employed. An important conclusion of this review is that even though microfluidic technology has been in this field for around 20 years there is still room for research and development, as this cutting edge technology requires ingenuity to design and find solutions for each individual case. Recent extensions of these microsystems are microengineered organs-on-chips and organ arrays. (C) 2016 AIP Publishing LLC.